Literature DB >> 4917724

A controlled trial of cyclophosphamide in rheumatoid arthritis.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4917724     DOI: 10.1056/NEJM197010222831701

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up.

Authors:  A A Drosos; D Psychos; A P Andonopoulos; S Stefanaki-Nikou; E B Tsianos; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis.

Authors:  P L Van Riel; A Larsen; L B Van de Putte; F W Gribnau
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

3.  Methotrexate therapy in rheumatoid arthritis. Current status.

Authors:  W S Wilke; A H Mackenzie
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

4.  Radiological evaluation of erosions: a quantitative method for assessing long-term remittive therapy in rheumatoid arthritis.

Authors:  W M O'Brien
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 5.  Joint damage in rheumatoid arthritis: radiological assessments and the effects of anti-rheumatic drugs.

Authors:  D L Scott; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

6.  Kinetics of the reactive cell clones after immunosuppression and induction of tolerance: (1) inhibition of 19 S and 7 S plaque-forming cells in the primary and secondary immune response to sheep red blood cells by cyclophosphamide and 036.5122 (Asta).

Authors:  U Botzenhardt; E M Lemmel
Journal:  Agents Actions       Date:  1975-12

7.  The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.

Authors:  A Larsen; J Horton; C Howland
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

8.  Long-term second-line therapy in rheumatoid arthritis.

Authors:  H A Bird
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

Review 9.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

10.  The assessment of radiological changes in the hands and wrists in rheumatoid arthritis.

Authors:  K A Grindulis; D L Scott; G R Struthers
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.